Amalgamated Bank’s DarioHealth DRIO Stock Holding History

Amalgamated Bank’s Portfolio DRIO Stock Details DRIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-81	Closed	-$9K	–	3077
2022 Q1	$9K	Buy	+81	New	+$13.4K	﹤0.01%	2973

Other funds holding DRIO

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

CHM

Collaborative Holdings Management New York $49.2M AUM 119.38% 1-Year Est. Return

AWAM

Appian Way Asset Management New York $558M AUM 1.95% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Amalgamated Bank's DRIO Position: Q2 2022 in Review

Amalgamated Bank sold out of DarioHealth (DRIO) in Q2 2022, closing a stake of 81 shares — an estimated $9K sold.

Amalgamated Bank first reported a position in DRIO in Q1 2022 and held it in 1 quarter. The position peaked at $9K in Q1 2022. 58 funds tracked by Wall St. Rank hold DRIO as of Q2 2022.

Amalgamated Bank reported no remaining DarioHealth position as of Q2 2022 after selling out during the quarter.
Amalgamated Bank sold 81 DarioHealth shares in Q2 2022, an estimated $9K.
Amalgamated Bank first reported a position in DarioHealth in Q1 2022 and held it in 1 quarter.
Amalgamated Bank's DarioHealth position peaked at $9K in Q1 2022.
58 funds tracked by Wall St. Rank held DarioHealth as of Q2 2022.

Based on Amalgamated Bank's 13F filing for Q2 2022, filed 15 Aug 2022.